
Joseph Friedman, MD
Psychiatry
About Me
Schizophrenia Psychopharmacology Research Program
Clinical Focus:
- Metabolic Encephalopathy
- ICU Delirium
- Neuropsychopharmacology
- Neuroimaging
- Psychotic Disorders
- Cardiovascular Disease and Associated Brain Dysfunction
- Toxic Encephalopathy
- Behavioral Issues In ICU Patients
- Neuropsychology
- Neurodegenerative Disorders
- Geriatric Psychiatry
- Traumatic Brain Injury
Hospital Affiliations:
The Mount Sinai Hospital, Mount Sinai Morningside and Mount Sinai West
Phone: MSH Delirium Services 212-241-7901
Language
English
Position
PROFESSOR | Psychiatry, PROFESSOR | Neuroscience
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Education
MD, Medical College of Wisconsin
Residency, Psychiatry
Mount Sinai Hospital
Fellowship, Psychiatry
Mount Sinai Hospital
Awards
1998
Kempf Fund Award for Research Development in Psychobiological Psychiatry
American Psychiatric Association
1998
Physician Loan Forgiveness Award
New York State
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Machine Learning Multimodal Model for Delirium Risk Stratification. Joseph I. Friedman, Prathamesh Parchure, Fu Yuan Cheng, Weijia Fu, Satyanarayana Cheertirala, Prem Timsina, Ganesh Raut, Katherine Reina, Josiane Joseph-Jimerson, Madhu Mazumdar, Robert Freeman, David L. Reich, Arash Kia. JAMA network open
- Distinct genetic liability profiles define clinically relevant patient strata across common diseases. Lucia Trastulla, Georgii Dolgalev, Sylvain Moser, Laura T. Jiménez-Barrón, Till F.M. Andlauer, Moritz von Scheidt, Douglas M. Ruderfer, Stephan Ripke, Andrew McQuillin, Eli A. Stahl, Enrico Domenici, Rolf Adolfsson, Ingrid Agartz, Esben Agerbo, Margot Albus, Madeline Alexander, Farooq Amin, Silviu A. Bacanu, Martin Begemann, Richard A. Belliveau, Judit Bene, Sarah E. Bergen, Elizabeth Bevilacqua, Tim B. Bigdeli, Donald W. Black, Douglas H.R. Blackwood, Anders D. Borglum, Elvira Bramon, Richard Bruggeman, Nancy G. Buccola, Randy L. Buckner, Brendan Bulik-Sullivan, Joseph D. Buxbaum, William Byerley, Wiepke Cahn, Guiqing Cai, Dominique Campion, Rita M. Cantor, Vaughan J. Carr, Noa Carrera, Stanley V. Catts, David Cohen, Kenneth L. Davis, Elodie Drapeau, Joseph I. Friedman, Vahram Haroutunian, René S. Kahn, Abraham Reichenberg, Panos Roussos, Jeremy M. Silverman. Nature Communications
- Schizophrenia-associated somatic copy-number variants from 12,834 cases reveal recurrent NRXN1 and ABCB11 disruptions. Eduardo A. Maury, Maxwell A. Sherman, Giulio Genovese, Thomas G. Gilgenast, Tushar Kamath, S. J. Burris, Prashanth Rajarajan, Erin Flaherty, Schahram Akbarian, Andrew Chess, Steven A. McCarroll, Po Ru Loh, Jennifer E. Phillips-Cremins, Kristen J. Brennand, Evan Z. Macosko, James T.R. Walters, Michael O'Donovan, Patrick Sullivan, Christian R. Marshall, Daniele Merico, Bhooma Thiruvahindrapuram, Zhouzhi Wang, Stephen W. Scherer, Daniel P. Howrigan, Stephan Ripke, Brendan Bulik-Sullivan, Kai How Farh, Menachem Fromer, Jacqueline I. Goldstein, Hailiang Huang, Phil Lee, Mark J. Daly, Benjamin M. Neale, Richard A. Belliveau, Sarah E. Bergen, Elizabeth Bevilacqua, Kimberley D. Chambert, Colm O'Dushlaine, Dalila Pinto, Guiqing Cai, Kenneth L. Davis, Elodie Drapeau, Joseph I. Friedman, Vahram Haroutunian, Abraham Reichenberg, Jeremy M. Silverman, René S. Kahn, David Cohen, Panos Roussos, Chaggai Rosenbluh. Cell Genomics
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Friedman has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.